Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Parkinson, Joel T"'
Autor:
Parkinson, Joel T.
Conventional treatments for depression, such as pharmacological interventions, are often ineffective. Up to half of patients do not respond, resulting in a poor prognosis for depression. Therefore, treatment options can be invaluable for increasing r
Externí odkaz:
https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.737951
Autor:
Stefanov, Kristian *, Al-Wasity, Salim, Parkinson, Joel T, Waiter, Gordon D, Cavanagh, Jonathan, Basu, Neil
Publikováno v:
In The Lancet Rheumatology February 2023 5(2):e99-e109
Publikováno v:
In Comprehensive Psychoneuroendocrinology November 2021 8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Whether depressed patients with evidence of inflammation are more appropriate candidates for immunotherapies is being tested in several clinical trials, which are selecting patients based on elevated C-reactive protein (CRP) and inflammation-related
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ae694f300be39a6e824571aed843c0
https://www.repository.cam.ac.uk/handle/1810/326409
https://www.repository.cam.ac.uk/handle/1810/326409
Autor:
Foley, Éimear M., Parkinson, Joel T., Mitchell, Ruth E., Turner, Lorinda, Khandaker, Golam M.
Publikováno v:
Molecular Psychiatry; March 2023, Vol. 28 Issue: 3 p1004-1019, 16p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Depression is a major neuropsychiatric disorder common in patients with rheumatological conditions including spondyloarthritis (SpA). It is associated with higher disease activity, functional impairment, poor treatment response and quality of life in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80de8beb7a8e47e775621560108f054c
Funder: MQ: Transforming Mental Health; FundRef: https://doi.org/10.13039/501100008162; Grant(s): MQDS17/40
Funder: cambridge trust; FundRef: https://doi.org/10.13039/501100003343
Depression is a major neuropsychiatric disorder common in pa
Funder: cambridge trust; FundRef: https://doi.org/10.13039/501100003343
Depression is a major neuropsychiatric disorder common in pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c82229b01d4f196d432c98f728945bfa
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 12 (2020)
Parkinson, J T, Foley, É M, Jadon, D R & Khandaker, G M 2020, ' Depression in patients with spondyloarthritis : prevalence, incidence, risk factors, mechanisms and management ', Therapeutic advances in musculoskeletal disease, vol. 12 . https://doi.org/10.1177/1759720X20970028
Therapeutic Advances in Musculoskeletal Disease
Parkinson, J T, Foley, É M, Jadon, D R & Khandaker, G M 2020, ' Depression in patients with spondyloarthritis : prevalence, incidence, risk factors, mechanisms and management ', Therapeutic advances in musculoskeletal disease, vol. 12 . https://doi.org/10.1177/1759720X20970028
Therapeutic Advances in Musculoskeletal Disease
Depression is a major neuropsychiatric disorder common in patients with rheumatological conditions including spondyloarthritis (SpA). It is associated with higher disease activity, functional impairment, poor treatment response and quality of life in